N. Sakaki et al., PRELIMINARY CLINICAL-STUDY ON GASTRIC-ULCER SCARS AND ULCER RELAPSES AFTER HELICOBACTER-PYLORI ERADICATION THERAPY, Journal of clinical gastroenterology, 25, 1997, pp. 229-234
To determine the effect of Helicobacter pylori eradication on the heal
ing of gastric ulcers, endoscopic examinations of gastric ulcer scars
and ulcer relapse after eradication therapies or antisecretory therapy
were carried out in 24 H. pylori-positive patients with recurrent gas
tric ulcers located in the gastric angle. Sixteen patients were initia
lly treated with 2-week triple eradication therapy. Subsequently, seve
n of eight noneradicated cases were retreated with triple therapy, whi
ch included metronidazole. Eight patients received antisecretory monot
herapy. Endoscopic examinations were performed at 4 weeks and 6 months
after the treatments. Gastric ulcer scars were classified endoscopica
lly into three types: Sa, a central depression surrounded by a coarse
pattern; Sb, a coarse regenerated pattern; and Sc, a fine pattern indi
cating matured scar of high quality. Transformations of the scar patte
rns and ulcer relapse were assessed in 19 patients who showed an ulcer
scar at 4 weeks after initial therapy. Thirteen cases in which H. pyl
ori was successfully eradicated, either after initial or re-eradicatio
n therapies, mainly showed Sc scars and had no ulcer relapse. Sa scar
was mainly observed during H. pylori-positive conditions. Transformati
on from the Sa to the Sc was observed after successful re-eradication.
Ulcer relapses occurred in three patients who showed Sa scar after an
tisecretory therapy. Although a random study would be needed to obtain
a definite conclusion, we suspect that the H. pylori-negative conditi
on after eradication therapies may result in good ulcer healing and ma
y subsequently reduce ulcer relapse.